Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment
International Journal of Biological Sciences · 2024 · 20 (10) · 3911-3922
DOI: 10.7150/ijbs.93697 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Racheli Birnboim-Perach und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Biotechnology, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sci…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 54-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology and Biotechnology, The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 69978, Israel.
- Cancer Biology Research Center, Tel Aviv University, Tel-Aviv 69978, Israel.
- The Tel Aviv University Center for Combatting Pandemics, Tel-Aviv University, Tel-Aviv 69978, Israel.
Zitieren
APA
Birnboim-Perach, R., & Benhar, I. (2024). Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment. International Journal of Biological Sciences, 20(10), 3911-3922. https://doi.org/10.7150/ijbs.93697
Vancouver
Birnboim-Perach R, Benhar I. Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment. International Journal of Biological Sciences. 2024;20(10):3911-3922. doi:10.7150/ijbs.93697
BibTeX
@article{BirnboimPerach2024,
author = {Birnboim-Perach, Racheli and Benhar, Itai},
title = {Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {10},
pages = {3911--3922},
doi = {10.7150/ijbs.93697}
}
EUVIMED